COLLEEN SUN: Open Payments
NPI 1447925912 · ROSEMEAD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$603 in 8 payments from 4 companies in 2025. Trend: 2023 $784 · 2024 $909 · 2025 $603
Food & beverage: $603
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 5 | $320 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $130 |
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
| Alkermes, Inc. | 1 | $31 |
Products named: INVEGA SUSTENNA, CAPLYTA, COBENFY, ARISTADA.
Industry payments across CA — which companies pay providers there.
